PPP2R5D (Q14738) variants and mutations
PPP2R5D (also known as Q14738) is a human protein-coding gene encoding a serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform protein. It directs the PP2A phosphatase toward specific signaling substrates in neurons and other cells, helping control phosphorylation-dependent growth and synaptic pathways. De novo pathogenic variants cause Jordan's syndrome, with developmental delay, intellectual disability, hypotonia, and often macrocephaly. This analysis covers 709 PPP2R5D variants and mutations. Of these, 90% have computational variant effect predictions. Disease context includes Hogue-Janssens syndrome 1, Intellectual disability, and cancer. Example PPP2R5D variants include P2S, P2T, and P2P.
Variant analysis overview
- Gene: PPP2R5D
- Protein: Q14738
- UniProt accession: Q14738
- Organism: Homo sapiens
- Variants analyzed: 709
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 499 unspecified-consequence records; 79 missense variants; 104 synonymous variants; 9 frameshift variants; 8 in-frame deletions; 2 in-frame insertions; 2 stop-gained variants; 1 splice-region variants; 5 substitution
- Prediction scores: 641 variants have prediction scores (90% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Hogue-Janssens syndrome 1, Intellectual disability, cancer, neurodegenerative disease, hereditary disease, genetic developmental and epileptic encephalopathy, chronic myelogenous leukemia, BCR-ABL1 positive, complex neurodevelopmental disorder, neurodevelopmental disorder, Neurodevelopmental delay, Global developmental delay, Neurodevelopmental abnormality.
Protein structure and variant hotspots
- Protein features: 6 post-translational modification sites.
- PTM context: 11 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable PPP2R5D variants
Examples include P2S, P2T, P2P, Y3F, Y3H, Y3Y, K4E, K4N. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- P2S (p.Pro2Ser), cosmic curated COSV10436, TOPMed rs1029888036, gnomAD rs1029888036, REVEL 0.08, MetaLR 0.15
- P2T (p.Pro2Thr), gnomAD 6-42984681-C-A, REVEL 0.14, MetaLR 0.15
- P2P (p.Pro2Pro), rs2150245527, gnomAD 6-42984683-C-T, CADD 15.80
- Y3F (p.Tyr3Phe), rs2150245534, ClinGen CA364172508, ClinVar RCV001576360, Ensembl rs2150245534, REVEL 0.19, MetaLR 0.04, Conflicting interpretations, not provided
- Y3H (p.Tyr3His), Ensembl rs1770689122, MetaLR 0.05, MetaSVM -0.90
- Y3Y (p.Tyr3Tyr), gnomAD 6-42984686-T-C, CADD 14.20
- K4E (p.Lys4Glu), Ensembl rs1561835736, MetaLR 0.15, MetaSVM -0.88
- K4N (p.Lys4Asn), gnomAD rs958700013, REVEL 0.13, MetaLR 0.15
- L5V (p.Leu5Val), gnomAD 6-42984690-C-G, REVEL 0.12, MetaLR 0.03
- L5L (p.Leu5Leu), rs752038217, gnomAD 6-42984690-C-T, CADD 15.80
- L5P (p.Leu5Pro), gnomAD 6-42984691-T-C, REVEL 0.22, MetaLR 0.04
- K6T (p.Lys6Thr), gnomAD 6-42984694-A-C, REVEL 0.18, MetaLR 0.15
- K6K (p.Lys6Lys), gnomAD 6-42984695-A-G, CADD 15.20
- K7R (p.Lys7Arg), gnomAD 6-42984692-GA-G, CADD 29.80
- K7K (p.Lys7Lys), rs781752811, gnomAD 6-42984698-G-A, CADD 15.40
- E8G (p.Glu8Gly), gnomAD 6-42984700-A-G, REVEL 0.12, MetaLR 0.11
- E8E (p.Glu8Glu), gnomAD 6-42984701-G-A, CADD 14.40
- K9M (p.Lys9Met), gnomAD rs1203581990, REVEL 0.16, AlphaMissense 0.38
- K9T (p.Lys9Thr), rs1203581990, ClinGen CA364172787, ClinVar RCV002848213, AlphaMissense 0.38, MetaLR 0.21, Uncertain significance, not provided
- K9del (p.Lys9del), rs768198586, gnomAD 6-42984699-GAGA-G, CADD 22.70
- E10D (p.Glu10Asp), Ensembl rs1771107532, REVEL 0.11, MetaLR 0.11
- P11A (p.Pro11Ala), rs1181904491, ClinGen CA364174586, ClinVar RCV003577553, AlphaMissense 0.06, MetaLR 0.05, Uncertain significance, not provided
- P11H (p.Pro11His), TOPMed rs1439101816, gnomAD rs1439101816, REVEL 0.15, MetaLR 0.12
- P11S (p.Pro11Ser), rs1181904491, NCI-TCGA Cosmic COSV5784, cosmic curated COSV57840, TOPMed rs1181904491, REVEL 0.07, AlphaMissense 0.06, Variant assessed as somatic; moderate impact.
- P11P (p.Pro11Pro), rs1389745597, gnomAD 6-42989616-C-T, CADD 10.00
- P12H (p.Pro12His), TOPMed rs1306373469, gnomAD rs1306373469, REVEL 0.18, MetaLR 0.18
- P12L (p.Pro12Leu), TOPMed rs1306373469, gnomAD rs1306373469, REVEL 0.14, MetaLR 0.15
- P12R (p.Pro12Arg), TOPMed rs1306373469, gnomAD rs1306373469, REVEL 0.14, MetaLR 0.15
- P12S (p.Pro12Ser), Ensembl rs1771108383, MetaLR 0.08, MetaSVM -1.06
- P12P (p.Pro12Pro), gnomAD 6-42989619-C-A, CADD 11.40
- K13E (p.Lys13Glu), rs1264664886, ClinGen CA364174637, ClinVar RCV003026129, TOPMed rs1264664886, AlphaMissense 0.22, MetaLR 0.22, Uncertain significance, not provided
- K13R (p.Lys13Arg), rs144675117, ClinGen CA3811719, ClinVar RCV003863001, ESP rs144675117, REVEL 0.14, MetaLR 0.22, Uncertain significance, not provided
- K13K (p.Lys13Lys), gnomAD 6-42989622-G-A, CADD 9.95
- V14I (p.Val14Ile), rs1771109410, ClinGen CA364174662, ClinVar RCV003553142, TOPMed rs1771109410, REVEL 0.08, MetaLR 0.03, Uncertain significance, not provided
- p.Ala15 Lys16insIle, gnomAD 6-42989628-C-CATT, CADD 21.00
- K16K (p.Lys16Lys), gnomAD 6-42989631-A-G, CADD 11.90
- C17Y (p.Cys17Tyr), NCI-TCGA TCGA novel, REVEL 0.19, MetaLR 0.05, Variant assessed as somatic; moderate impact.
- T18I (p.Thr18Ile), Ensembl rs2150251136, REVEL 0.08, MetaLR 0.03
- A19V (p.Ala19Val), TOPMed rs1241422647, gnomAD rs1241422647, REVEL 0.12, MetaLR 0.05
- A19A (p.Ala19Ala), rs748170805, gnomAD 6-42989640-C-T, CADD 14.20
- K20R (p.Lys20Arg), NCI-TCGA TCGA novel, MetaLR 0.17, MetaSVM -1.05, Variant assessed as somatic; moderate impact.
- K20Q (p.Lys20Gln), gnomAD 6-42989641-A-C, REVEL 0.13, MetaLR 0.17
- K20K (p.Lys20Lys), rs772232789, gnomAD 6-42989643-G-A, CADD 10.40
- P21S (p.Pro21Ser), ExAC rs773110780, gnomAD rs773110780, REVEL 0.09, MetaLR 0.06
- P21P (p.Pro21Pro), rs1771110543, gnomAD 6-42989646-T-G, CADD 12.20
- S22G (p.Ser22Gly), TOPMed rs1190348868, gnomAD rs1190348868, REVEL 0.06, MetaLR 0.04
- S22N (p.Ser22Asn), rs373458153, ClinGen CA3811723, ClinVar RCV002026720, ESP rs373458153, REVEL 0.11, MetaLR 0.05, Uncertain significance, not provided
- S22R (p.Ser22Arg), gnomAD 6-42989649-C-G, REVEL 0.13, MetaLR 0.08
- S23G (p.Ser23Gly), NCI-TCGA TCGA novel, MetaLR 0.04, MetaSVM -1.12, Variant assessed as somatic; moderate impact.
- S23R (p.Ser23Arg), gnomAD 6-42989650-A-C, REVEL 0.17, MetaLR 0.05
- S23N (p.Ser23Asn), gnomAD 6-42989651-G-A, REVEL 0.11, MetaLR 0.04
- S23S (p.Ser23Ser), rs1422815936, gnomAD 6-42989652-C-T, CADD 12.10
- S24L (p.Ser24Leu), rs770645870, ClinGen CA3811724, cosmic curated COSV57839, ClinVar RCV000900015, REVEL 0.11, MetaLR 0.05, Benign/Likely benign, not provided
- S24S (p.Ser24Ser), gnomAD 6-42989655-G-C, CADD 1.95
- G25C (p.Gly25Cys), TOPMed rs1226397734, gnomAD rs1226397734, REVEL 0.17, MetaLR 0.11
- G25A (p.Gly25Ala), gnomAD 6-42989657-G-C, REVEL 0.18, MetaLR 0.06
- K26* (p.Lys26Ter), NCI-TCGA Cosmic COSV5784, cosmic curated COSV57840, Variant assessed as somatic; high impact.
- K26Q (p.Lys26Gln), Ensembl rs2150251166, REVEL 0.12, MetaLR 0.18
- D27H (p.Asp27His), Ensembl rs1771111944
- D27N (p.Asp27Asn), NCI-TCGA Cosmic COSV5783, cosmic curated COSV57839, MetaLR 0.11, MetaSVM -1.01, Variant assessed as somatic; moderate impact.
- D27A (p.Asp27Ala), gnomAD 6-42989663-A-C, REVEL 0.19, MetaLR 0.14
- G28G (p.Gly28Gly), rs759434552, gnomAD 6-42989667-T-C, CADD 11.90
- G29R (p.Gly29Arg), Ensembl rs760781912, MetaLR 0.06, MetaSVM -1.03
- G30G (p.Gly30Gly), gnomAD 6-42989673-C-T, CADD 22.20
- E31K (p.Glu31Lys), rs764794443, ClinGen CA364175039, ClinVar RCV001992081, ExAC rs764794443, REVEL 0.17, MetaLR 0.05, Uncertain significance, not provided
- E31Q (p.Glu31Gln), ExAC rs764794443, TOPMed rs764794443, gnomAD rs764794443, REVEL 0.23, MetaLR 0.07, Uncertain significance, Inborn genetic diseases
- E31E (p.Glu31Glu), gnomAD 6-42989676-G-A, CADD 9.38
- N32N (p.Asn32Asn), rs1162385186, gnomAD 6-42989679-C-T, CADD 6.29
- T33T (p.Thr33Thr), gnomAD 6-42989682-T-C, CADD 2.79
- E34A (p.Glu34Ala), rs1241116131, ClinGen CA364175108, ClinVar RCV001336932, ClinVar RCV001865856, REVEL 0.11, MetaLR 0.07, Uncertain significance, not provided; Houge-Janssens syndrome 1
- E34K (p.Glu34Lys), rs2481338535, ClinGen CA364175100, NCI-TCGA Cosmic COSV1000, ClinVar RCV003710339, Uncertain significance, not provided
- E35G (p.Glu35Gly), gnomAD 6-42989687-A-G, REVEL 0.22, MetaLR 0.06
- A36P (p.Ala36Pro), gnomAD 6-43006463-G-C, REVEL 0.05, CADD 23.00
- A36D (p.Ala36Asp), gnomAD 6-43006464-C-A, REVEL 0.10, CADD 15.70
- Q37* (p.Gln37Ter), TOPMed rs1762084622
- Q37R (p.Gln37Arg), gnomAD 6-43006467-A-G, REVEL 0.16, CADD 17.00
- Q37Q (p.Gln37Gln), rs762701818, gnomAD 6-43006468-G-A, CADD 9.40, SIFT 0.77
- P38L (p.Pro38Leu), rs200268619, ClinGen CA3811750, ClinVar RCV001883919, 1000Genomes rs200268619, REVEL 0.12, CADD 19.80, Uncertain significance, not provided
- P38S (p.Pro38Ser), rs2532471420, ClinGen CA364178305, ClinVar RCV003023613, Uncertain significance, not provided
- P38P (p.Pro38Pro), rs774008462, gnomAD 6-43006471-G-A, CADD 2.17, SIFT 0.03
- Q39H (p.Gln39His), rs761463281, ClinGen CA364178428, ClinVar RCV001912139, ExAC rs761463281, AlphaMissense 0.13, MetaLR 0.03, Uncertain significance, not provided
- Q39Q (p.Gln39Gln), rs761463281, gnomAD 6-43006474-G-A, AlphaMissense 0.13, MetaLR 0.03
- P40L (p.Pro40Leu), gnomAD rs1360349628, REVEL 0.07, CADD 15.40
- P40T (p.Pro40Thr), rs1286366363, ClinGen CA364178430, ClinVar RCV003576831, gnomAD rs1286366363, REVEL 0.03, CADD 4.42, Uncertain significance, not provided
- P40R (p.Pro40Arg), gnomAD 6-43006476-C-G, REVEL 0.06, CADD 15.00
- P40P (p.Pro40Pro), rs1762086551, gnomAD 6-43006477-C-G, CADD 2.30, SIFT 0.00
- Q41E (p.Gln41Glu), Ensembl rs891269934, SIFT 0.06
- p.Gln41 Pro42insThrGln, gnomAD 6-43006475-C-CCCC, CADD 13.20
- P42L (p.Pro42Leu), 1000Genomes rs544371066, ExAC rs544371066, gnomAD rs544371066, REVEL 0.07, CADD 17.00
- P42T (p.Pro42Thr), rs766986033, ClinGen CA3811757, ClinVar RCV001911201, ExAC rs766986033, REVEL 0.04, CADD 12.50, Uncertain significance, not provided
- p.Pro42 Gln47del, rs761162230, gnomAD 6-43006463-GCCCAG, CADD 17.20
- P42P (p.Pro42Pro), rs1344853175, gnomAD 6-43006483-C-A, CADD 1.78, SIFT 0.05
- Q43K (p.Gln43Lys), gnomAD 6-43006484-C-A, REVEL 0.08, CADD 13.60
- p.Pro44 Gln47del, gnomAD 6-43006463-GCCCAG, CADD 17.40
- P44S (p.Pro44Ser), gnomAD 6-43006487-C-T, REVEL 0.03, CADD 5.43
- P44H (p.Pro44His), gnomAD 6-43006488-C-A, REVEL 0.11, CADD 12.70
- P44P (p.Pro44Pro), rs1452907455, gnomAD 6-43006489-C-G, CADD 2.01, SIFT 0.01
- Q45Q (p.Gln45Gln), rs759796179, gnomAD 6-43006492-G-A, CADD 7.84, SIFT 0.53
- P46L (p.Pro46Leu), gnomAD rs1762088356, REVEL 0.05, CADD 19.00, Uncertain significance, not provided
- p.Pro46 Gln47del, gnomAD 6-43006471-GCAGCC, CADD 16.40
- P46S (p.Pro46Ser), gnomAD 6-43006493-C-T, REVEL 0.05, CADD 12.90
- P46R (p.Pro46Arg), gnomAD 6-43006494-C-G, REVEL 0.06, CADD 17.60
- Q47Q (p.Gln47Gln), rs765656201, gnomAD 6-43006498-A-G, CADD 5.14, SIFT 0.43
- A48V (p.Ala48Val), ExAC rs752822476, gnomAD rs752822476, REVEL 0.09, CADD 13.30
- A48T (p.Ala48Thr), gnomAD 6-43006499-G-A, REVEL 0.01, CADD 3.68
- A48A (p.Ala48Ala), rs758659914, gnomAD 6-43006501-C-A, CADD 3.42, SIFT 0.00
- Q49R (p.Gln49Arg), rs370441625, ClinGen CA3811763, ClinVar RCV002025622, ESP rs370441625, AlphaMissense 0.13, MetaLR 0.02, Uncertain significance, not provided
- S50F (p.Ser50Phe), rs2150277755, ClinGen CA364178906, ClinVar RCV001996566, Ensembl rs2150277755, AlphaMissense 0.14, MetaLR 0.05, Uncertain significance, not provided
- S50S (p.Ser50Ser), gnomAD 6-43006507-T-A, CADD 4.00, SIFT 0.10
- Q51H (p.Gln51His), TOPMed rs1762089282, gnomAD rs1762089282, REVEL 0.09, CADD 17.70, Uncertain significance, not provided
- Q51Q (p.Gln51Gln), gnomAD 6-43006510-G-A, CADD 7.65, SIFT 0.20
- P52L (p.Pro52Leu), gnomAD rs1561849382, REVEL 0.05, CADD 20.80
- P52T (p.Pro52Thr), Ensembl rs1581851242, SIFT 0.11
- P52P (p.Pro52Pro), gnomAD 6-43006513-A-T, CADD 5.58, SIFT 0.06
- P53L (p.Pro53Leu), rs1421653493, ClinGen CA364179040, ClinVar RCV001969257, TOPMed rs1421653493, REVEL 0.03, CADD 15.00, Uncertain significance, not provided
- P53S (p.Pro53Ser), rs757369209, ClinGen CA355020, ClinVar RCV000201513, UniProt VAR 069414, AlphaMissense 0.06, MetaLR 0.02, Pathogenic, Houge-Janssens syndrome 1
- P53T (p.Pro53Thr), ExAC rs757369209, gnomAD rs757369209, REVEL 0.07, AlphaMissense 0.06, Pathogenic, in HJS1
- P53del (p.Pro53del), gnomAD 6-43006510-GCCA-G, CADD 16.40
- P53A (p.Pro53Ala), gnomAD 6-43006514-C-G, REVEL 0.04, CADD 5.05
- P53P (p.Pro53Pro), rs141996737, gnomAD 6-43006516-G-A, CADD 0.43, SIFT 0.13
- S54L (p.Ser54Leu), NCI-TCGA TCGA novel, SIFT 0.11, Variant assessed as somatic; moderate impact.
- S54P (p.Ser54Pro), rs1226113951, ClinGen CA364179059, ClinVar RCV001336933, TOPMed rs1226113951, REVEL 0.01, CADD 10.80, Uncertain significance, Houge-Janssens syndrome 1
- S54S (p.Ser54Ser), rs1762090482, gnomAD 6-43006519-A-G, CADD 6.55, SIFT 0.74
- S55F (p.Ser55Phe), rs1762090621, ClinGen CA364179138, ClinVar RCV002616293, TOPMed rs1762090621, AlphaMissense 0.20, MetaLR 0.09, Uncertain significance, not provided
- S55del (p.Ser55del), gnomAD 6-43006516-GTCA-G, CADD 15.00
- N56H (p.Asn56His), rs1561849418, ClinGen CA364179151, ClinVar RCV002587846, Ensembl rs1561849418, AlphaMissense 0.12, MetaLR 0.05, Uncertain significance, not provided
- N56K (p.Asn56Lys), rs745843787, ClinGen CA3811767, ClinVar RCV003493140, ExAC rs745843787, AlphaMissense 0.51, MetaLR 0.03, Uncertain significance, Houge-Janssens syndrome 1
- R58C (p.Arg58Cys), rs1394527818, ClinGen CA364179301, ClinVar RCV001988485, TOPMed rs1394527818, REVEL 0.10, CADD 27.30, Uncertain significance, not provided
- R58H (p.Arg58His), rs769440183, ClinGen CA3811768, cosmic curated COSV57840, ClinVar RCV002012301, REVEL 0.09, CADD 25.00, Uncertain significance, not specified; not provided
- R58S (p.Arg58Ser), NCI-TCGA TCGA novel, SIFT 0.02, Variant assessed as somatic; moderate impact.
- P59S (p.Pro59Ser), rs376202873, ClinGen CA3811769, ClinVar RCV003273781, ClinVar RCV003730511, AlphaMissense 0.17, MetaLR 0.05, Uncertain significance, Inborn genetic diseases; not provided
- P59L (p.Pro59Leu), gnomAD 6-43006533-C-T, REVEL 0.11, CADD 22.30
- S60G (p.Ser60Gly), gnomAD 6-43006535-A-G, REVEL 0.12, CADD 21.00
- S60R (p.Ser60Arg), gnomAD 6-43006537-C-G, REVEL 0.14, CADD 19.40
- N61D (p.Asn61Asp), Ensembl rs867015757, SIFT 0.01
- S62C (p.Ser62Cys), TOPMed rs1038667663, Uncertain significance
- S62G (p.Ser62Gly), rs1038667663, ClinGen CA364179505, ClinVar RCV001767872, TOPMed rs1038667663, AlphaMissense 0.12, MetaLR 0.05, Uncertain significance, not provided
- T63M (p.Thr63Met), rs370244516, ClinGen CA3811770, cosmic curated COSV57839, ClinVar RCV002022735, REVEL 0.10, CADD 22.50, Conflicting interpretations, not provided
- T63K (p.Thr63Lys), gnomAD 6-43006545-C-A, REVEL 0.15, CADD 16.70
- T63T (p.Thr63Thr), rs897087723, gnomAD 6-43006546-G-A, CADD 2.36, SIFT 0.02
- P64L (p.Pro64Leu), rs1000620573, NCI-TCGA Cosmic COSV5783, cosmic curated COSV57839, TOPMed rs1000620573, REVEL 0.27, CADD 23.00, Variant assessed as somatic; moderate impact.
- P64R (p.Pro64Arg), TOPMed rs1000620573, SIFT 0.03
- P64P (p.Pro64Pro), rs765929202, gnomAD 6-43006549-G-A, CADD 0.31, SIFT 0.03
- P65T (p.Pro65Thr), gnomAD 6-43006550-C-A, REVEL 0.19, CADD 23.40
- P65L (p.Pro65Leu), gnomAD 6-43006551-C-T, REVEL 0.25, CADD 24.50
- P65P (p.Pro65Pro), gnomAD 6-43006552-C-T, CADD 8.90, SIFT 0.01
- P66H (p.Pro66His), rs2532471802, ClinGen CA364179666, ClinVar RCV003064109, Uncertain significance, not provided
- P66T (p.Pro66Thr), Ensembl rs2150277826, SIFT 0.11
- P66S (p.Pro66Ser), gnomAD 6-43006553-C-T, REVEL 0.17, CADD 17.40
- P66P (p.Pro66Pro), rs146145609, gnomAD 6-43006555-C-A, CADD 0.17, SIFT 0.11
- T67M (p.Thr67Met), rs2532471813, ClinGen CA364179688, ClinVar RCV003691309, Uncertain significance, not provided
- T67R (p.Thr67Arg), NCI-TCGA TCGA novel, SIFT 0.00, Variant assessed as somatic; high impact.
- T67H (p.Thr67His), gnomAD 6-43006549-G-GC, CADD 24.50
- T67T (p.Thr67Thr), rs771755318, gnomAD 6-43006558-G-A, CADD 0.77, SIFT 0.03
- L69F (p.Leu69Phe), TOPMed rs1762093224, SIFT 0.00
- L69L (p.Leu69Leu), gnomAD 6-43006564-C-T, CADD 10.70, SIFT 1.00
- S70T (p.Ser70Thr), Ensembl rs1762093332, SIFT 0.06
- S70G (p.Ser70Gly), gnomAD 6-43006565-A-G, REVEL 0.07, CADD 21.90
- S70N (p.Ser70Asn), gnomAD 6-43006566-G-A, REVEL 0.13, CADD 17.60
- I72V (p.Ile72Val), rs1193111263, ClinGen CA364179925, ClinVar RCV002033164, TOPMed rs1193111263, REVEL 0.08, CADD 19.70, Uncertain significance, not provided
- I72T (p.Ile72Thr), gnomAD 6-43006572-T-C, REVEL 0.09, CADD 22.20
- K73R (p.Lys73Arg), rs776953962, ClinGen CA3811775, ClinVar RCV003831183, ExAC rs776953962, REVEL 0.13, CADD 23.10, Uncertain significance, not provided
- K73K (p.Lys73Lys), rs1007371103, gnomAD 6-43006576-G-A, CADD 12.50, SIFT 0.06
- S75P (p.Ser75Pro), ExAC rs760120524, gnomAD rs760120524, REVEL 0.22, CADD 22.60
- S75L (p.Ser75Leu), gnomAD 6-43006581-C-T, REVEL 0.25, CADD 23.00
- G76A (p.Gly76Ala), rs199635607, ClinGen CA3811777, ClinVar RCV002027934, ClinVar RCV005635447, REVEL 0.22, CADD 22.70, Uncertain significance, Houge-Janssens syndrome 1; not provided
- G76V (p.Gly76Val), 1000Genomes rs199635607, ExAC rs199635607, TOPMed rs199635607, gnomAD rs199635607, REVEL 0.34, CADD 23.00, Uncertain significance, Inborn genetic diseases
- G76G (p.Gly76Gly), gnomAD 6-43006585-G-C, AlphaMissense 0.09, MetaLR 0.29
- G77R (p.Gly77Arg), gnomAD rs1281707054, REVEL 0.24, CADD 23.20, Uncertain significance, not provided
- G77A (p.Gly77Ala), rs1478715149, gnomAD 6-43006581-CAG-C, CADD 31.00
- G77G (p.Gly77Gly), rs1012555767, gnomAD 6-43006588-G-A, CADD 5.07, SIFT 0.00
- P78A (p.Pro78Ala), NCI-TCGA TCGA novel, SIFT 0.02, Variant assessed as somatic; high impact.
- P78L (p.Pro78Leu), gnomAD 6-43006590-C-T, REVEL 0.12, CADD 23.60
- Q79L (p.Gln79Leu), rs763375514, ClinGen CA138249420, ClinVar RCV004552424, ExAC rs763375514, REVEL 0.09, AlphaMissense 0.41, Uncertain significance, PPP2R5D-related disorder
- Q79R (p.Gln79Arg), ExAC rs763375514, gnomAD rs763375514, REVEL 0.19, AlphaMissense 0.73, Uncertain significance
- I80T (p.Ile80Thr), NCI-TCGA Cosmic COSV5783, cosmic curated COSV57839, SIFT 0.00, Variant assessed as somatic; moderate impact.
- I80V (p.Ile80Val), gnomAD 6-43006595-A-G, REVEL 0.07, CADD 18.40
- I80M (p.Ile80Met), gnomAD 6-43006597-T-G, REVEL 0.06, CADD 15.60
- V81I (p.Val81Ile), Ensembl rs1762094447, REVEL 0.17, CADD 21.60, Uncertain significance, PPP2R5D-related disorder
- K82T (p.Lys82Thr), ExAC rs764271969, gnomAD rs764271969, SIFT 0.00
Public PPP2R5D analysis runs
- PPP2R5D analysis run — PPP2R5D (709 variants) — completed 2026-08-19